Kim L. O'Neill

Kim L. O'Neill is the developer of a monoclonal antibody that allows for the accurate, cheap and easy detection of cancer.

O'Neill has a B.Sc. degree from New University of Ulster and a Ph.D. from the University of Ulster. He is a full professor of microbiology at Brigham Young University. In 1998 research by O'Neill suggested a link between caffeine and the formation of some cancers.[1] O'Neill has served as associate director of BYU's cancer research center.

O'Neill is also a convert to the Church of Jesus Christ of Latter-day Saints, having joined the church in Ireland.

References
  1. Edward L. Carter, "BYU scientist finds caffeine may keep cancer cells alive", Deseret News, Jan. 22, 1998
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.